US Stock MarketDetailed Quotes

FBLG FibroBiologics

Watchlist
  • 2.620
  • +0.060+2.34%
Close Nov 29 13:00 ET
  • 2.750
  • +0.130+4.96%
Post 17:01 ET
90.81MMarket Cap-5000P/E (TTM)

FibroBiologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
63.35%3.35M
54.04%3.22M
52.32%3.45M
98.99%8.89M
90.18%2.48M
53.02%2.05M
2.09M
2.27M
183.08%4.47M
1.3M
Selling and administrative expenses
44.43%2.14M
45.47%2.25M
39.34%2.49M
96.42%6.52M
78.00%1.71M
49.14%1.48M
--1.55M
--1.79M
214.10%3.32M
--959K
-General and administrative expense
44.43%2.14M
45.47%2.25M
39.34%2.49M
96.42%6.52M
78.00%1.71M
49.14%1.48M
--1.55M
--1.79M
214.10%3.32M
--959K
Research and development costs
112.43%1.21M
78.24%975K
100.84%960K
106.45%2.37M
124.06%773K
64.08%571K
--547K
--478K
120.15%1.15M
--345K
Operating profit
-63.35%-3.35M
-54.04%-3.22M
-52.32%-3.45M
-98.99%-8.89M
-90.18%-2.48M
-53.02%-2.05M
-2.09M
-2.27M
-183.08%-4.47M
-1.3M
Net non-operating interest income expense
74K
750.00%65K
125.93%35K
77.52%-147K
99.55%-1K
0
-10K
-135K
-16,250.00%-654K
-220K
Non-operating interest income
--79K
--70K
--39K
----
----
--0
--0
--0
----
----
Non-operating interest expense
--5K
-50.00%5K
-97.04%4K
-77.52%147K
-99.55%1K
--0
--10K
--135K
16,250.00%654K
--220K
Other net income (expense)
2,070.21%2.78M
7,217.54%4.06M
-33,533.33%-5.05M
-7.45M
-7.24M
-141K
-57K
-15K
Gain on sale of security
--2.78M
--4.03M
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
101.42%2K
152.63%30K
-33,533.33%-5.05M
---7.45M
---7.24M
---141K
---57K
---15K
----
----
Income before tax
77.20%-500K
141.57%898K
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.40%-2.19M
-2.16M
-2.42M
-223.70%-5.12M
-1.52M
Income tax
Net income
77.20%-500K
141.57%898K
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.40%-2.19M
-2.16M
-2.42M
-223.70%-5.12M
-1.52M
Net income continuous Operations
77.20%-500K
141.57%898K
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.40%-2.19M
---2.16M
---2.42M
-223.70%-5.12M
---1.52M
Minority interest income
Net income attributable to the parent company
77.20%-500K
141.57%898K
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.40%-2.19M
-2.16M
-2.42M
-223.70%-5.12M
-1.52M
Preferred stock dividends
Other preferred stock dividends
0
0
0
2.57M
0
0
0
2.57M
0
0
Net income attributable to common stockholders
77.20%-500K
141.57%898K
-69.61%-8.46M
-272.15%-19.06M
-537.60%-9.72M
-40.40%-2.19M
-2.16M
-4.99M
-223.70%-5.12M
-1.52M
Basic earnings per share
85.19%-0.01
145.11%0.03
-75.80%-0.27
-272.15%-0.5868
-537.60%-0.2992
-40.40%-0.0675
-0.0665
-0.1536
-223.71%-0.1577
-0.0469
Diluted earnings per share
85.19%-0.01
145.11%0.03
-75.80%-0.27
-272.15%-0.5868
-537.60%-0.2992
-40.40%-0.0675
-0.0665
-0.1536
-223.71%-0.1577
-0.0469
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 63.35%3.35M54.04%3.22M52.32%3.45M98.99%8.89M90.18%2.48M53.02%2.05M2.09M2.27M183.08%4.47M1.3M
Selling and administrative expenses 44.43%2.14M45.47%2.25M39.34%2.49M96.42%6.52M78.00%1.71M49.14%1.48M--1.55M--1.79M214.10%3.32M--959K
-General and administrative expense 44.43%2.14M45.47%2.25M39.34%2.49M96.42%6.52M78.00%1.71M49.14%1.48M--1.55M--1.79M214.10%3.32M--959K
Research and development costs 112.43%1.21M78.24%975K100.84%960K106.45%2.37M124.06%773K64.08%571K--547K--478K120.15%1.15M--345K
Operating profit -63.35%-3.35M-54.04%-3.22M-52.32%-3.45M-98.99%-8.89M-90.18%-2.48M-53.02%-2.05M-2.09M-2.27M-183.08%-4.47M-1.3M
Net non-operating interest income expense 74K750.00%65K125.93%35K77.52%-147K99.55%-1K0-10K-135K-16,250.00%-654K-220K
Non-operating interest income --79K--70K--39K----------0--0--0--------
Non-operating interest expense --5K-50.00%5K-97.04%4K-77.52%147K-99.55%1K--0--10K--135K16,250.00%654K--220K
Other net income (expense) 2,070.21%2.78M7,217.54%4.06M-33,533.33%-5.05M-7.45M-7.24M-141K-57K-15K
Gain on sale of security --2.78M--4.03M--------------------------------
Other non- operating income (expenses) 101.42%2K152.63%30K-33,533.33%-5.05M---7.45M---7.24M---141K---57K---15K--------
Income before tax 77.20%-500K141.57%898K-250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.40%-2.19M-2.16M-2.42M-223.70%-5.12M-1.52M
Income tax
Net income 77.20%-500K141.57%898K-250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.40%-2.19M-2.16M-2.42M-223.70%-5.12M-1.52M
Net income continuous Operations 77.20%-500K141.57%898K-250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.40%-2.19M---2.16M---2.42M-223.70%-5.12M---1.52M
Minority interest income
Net income attributable to the parent company 77.20%-500K141.57%898K-250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.40%-2.19M-2.16M-2.42M-223.70%-5.12M-1.52M
Preferred stock dividends
Other preferred stock dividends 0002.57M0002.57M00
Net income attributable to common stockholders 77.20%-500K141.57%898K-69.61%-8.46M-272.15%-19.06M-537.60%-9.72M-40.40%-2.19M-2.16M-4.99M-223.70%-5.12M-1.52M
Basic earnings per share 85.19%-0.01145.11%0.03-75.80%-0.27-272.15%-0.5868-537.60%-0.2992-40.40%-0.0675-0.0665-0.1536-223.71%-0.1577-0.0469
Diluted earnings per share 85.19%-0.01145.11%0.03-75.80%-0.27-272.15%-0.5868-537.60%-0.2992-40.40%-0.0675-0.0665-0.1536-223.71%-0.1577-0.0469
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data